Anavex Life Sciences (AVXL) vs LENZ Therapeutics (LENZ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anavex Life Sciences (AVXL) has outperformed LENZ Therapeutics (LENZ) over the past year, losing 84.4% versus a loss of 92.7%. Over five years, AVXL leads with a -91.2% price change compared with -96.1% for LENZ. Anavex Life Sciences is the larger company by market cap ($138.1 million vs $114.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AVXL | LENZ |
|---|---|---|
| Share price | $1.49 | $3.65 |
| Market cap | $138.12M | $114.53M |
| 1-day change | -3.25% | +3.26% |
| YTD return | -56.74% | -77.94% |
| 1-year return | -84.37% | -92.74% |
| 5-year return | -91.21% | -96.05% |
| EPS (TTM) | $-0.14 | $-4.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.53 | $46.75 |
| 52-week low | $1.44 | $3.35 |
| Distance from 52-week high | -84.36% | -92.20% |
| Analyst consensus | none | none |
| Avg. price target upside | — | +558.44% |
| Average volume | 979.69K | 833.64K |
| Shares outstanding | 92.70M | 31.42M |
| Employees | 34 | 152 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Anavex Life Sciences
AVXL stock →Anavex Life Sciences Corp. operates as a biopharmaceutical company.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 34 employees
About LENZ Therapeutics
LENZ stock →LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 152 employees
AVXL vs LENZ FAQ
Which is bigger, Anavex Life Sciences or LENZ Therapeutics?
Anavex Life Sciences (AVXL) is larger, with a market capitalization of $138.12M compared with $114.53M for LENZ Therapeutics (LENZ).
Which stock has performed better over the past year, AVXL or LENZ?
AVXL returned -84.37% over the past 12 months, compared with -92.74% for LENZ (price return, excluding dividends). Past performance does not predict future results.
Are Anavex Life Sciences and LENZ Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.